NAMS
NewAmsterdam Pharma Company N.V. has filed 386 documents with the SEC between 2022 and 2026. The most frequent type is insider trade (101 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2026-05-26 | - |
| SCHEDULE 13D/A | - | 2026-05-14 | - |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Annual report to shareholders | ARS | 2026-05-06 | 2025-12-31 |
| Proxy statement | DEF 14A | 2026-05-06 | 2026-05-06 |
| SCHEDULE 13G/A | - | 2026-05-06 | - |
| Major company event | 8-K | 2026-04-24 | 2026-04-20 |
| PRE 14A | - | 2026-04-20 | 2026-04-20 |
| Insider trade | 4 | 2026-03-12 | 2026-03-11 |
| Insider sale notice | 144 | 2026-03-11 | - |
| Insider trade | 4 | 2026-03-10 | 2026-03-06 |
| Insider trade | 4 | 2026-03-09 | 2026-03-05 |
| Insider sale notice | 144 | 2026-03-06 | - |
| Insider sale notice | 144 | 2026-03-05 | - |
| Insider sale notice | 144 | 2026-03-02 | - |
| Insider trade | 4 | 2026-03-02 | 2026-03-02 |
| Major company event | 8-K | 2026-03-02 | 2026-03-02 |
| Insider trade | 4 | 2026-02-26 | 2026-02-24 |
| Insider sale notice | 144 | 2026-02-24 | - |
| Insider trade | 4 | 2026-02-24 | 2026-02-20 |
| Insider sale notice | 144 | 2026-02-20 | - |
| Employee stock plan | S-8 | 2026-02-18 | - |
| Annual report | 10-K | 2026-02-18 | 2025-12-31 |
| Major company event | 8-K | 2026-02-18 | 2026-02-18 |
| SCHEDULE 13G/A | - | 2026-02-17 | - |
| SCHEDULE 13G | - | 2026-02-05 | - |
| Insider trade | 4 | 2026-01-29 | 2026-01-27 |
| Insider trade | 4 | 2026-01-27 | 2026-01-23 |
| Insider trade | 4 | 2026-01-22 | 2026-01-20 |
| Insider sale notice | 144 | 2026-01-20 | - |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Major company event | 8-K | 2026-01-09 | 2026-01-09 |
| Insider sale notice | 144 | 2026-01-07 | - |
| Insider trade | 4 | 2026-01-07 | 2026-01-05 |
| Insider trade | 4 | 2026-01-07 | 2026-01-05 |
| Insider trade | 4 | 2026-01-07 | 2026-01-05 |
| Insider sale notice | 144 | 2026-01-06 | - |
| Insider sale notice | 144 | 2026-01-05 | - |
| Insider sale notice | 144 | 2026-01-05 | - |
| Insider sale notice | 144 | 2026-01-05 | - |
| Insider trade | 4 | 2025-12-29 | 2025-12-23 |
| Insider sale notice | 144 | 2025-12-23 | - |
| SCHEDULE 13D/A | - | 2025-12-04 | - |